Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 14.27 billion as of April 2, 2025. Its market cap has decreased by -3.24% in one year.

Market Cap

14.27B

Enterprise Value

16.32B

Revenue

5.38B

Ranking

n/a

PE Ratio

19.87

Stock Price

33.95

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 14.27B, an increase of 2,345.25%. That is a compound annual growth rate of 18.42%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	14.25B	-1.74%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	178.51B
Caliway Biopharmaceuticals	120.14B
Bora Pharmaceuticals Co., LTD.	71.17B
Lotus Pharmaceutical	61.56B
Oneness Biotech	33.46B
Lumosa Therapeutics	29.98B
Pegavision	28.08B
Center Laboratories	27.41B

Market Cap Rankings